Thomas Matthes
Plus aucun poste en cours
Profil
Thomas Matthes has been Director Business Development
Sloning BioTechnology in April 2007.
Previously he was at Sigma-Aldrich Chemie GmbH for 6 years where he was European Marketing Manager for the SAFC Division.
In 1996 Dr. Matthes joined CellSystems Biotechnologie GmbH as Sales Manager.
He held various scientific sales positions at Laboratories Eurobio in 1994.
Dr. Matthes began his career with the Paul-Ehrlich-Institute in Langen, Germany.
He is a Certified Biotech Engineer.
Anciens postes connus de Thomas Matthes
| Sociétés | Poste | Fin |
|---|---|---|
Sloning Bio Technology GmbH
 Sloning Bio Technology GmbH Miscellaneous Commercial ServicesCommercial Services Sloning BioTechnology specializes in the production of highly genetically diverse and precise customized libraries. The company offers high quality, innovative, tailored protein engineering solutions to its industrial and biopharmaceutical customers worldwide. As a business specializing in the development and production of genetically diverse libraries, Sloning BioTechnology GmbH offers high quality, innovative, tailored protein engineering solutions to its industrial and biopharmaceutical customers worldwide. The firm's Slonomics core technology is a unique DNA engineering platform that uses defined sets of double stranded DNA triplets to precisely introduce the required mutations into any DNA sequence. This multiply validated technology takes a novel approach to enable the realization of highly complex design concepts while at the same time ensuring that libraries generated by Sloning have the very highest standards of reliability. It harnesses the capabilities of Slonomics to synthesize SlonoMax and SlonoMax libraries are customized mutant libraries that significantly improve the efficiency of screening for new and improved proteins for therapeutic, enzymatic or technical applications. In addition, it offers a premium gene synthesis service using Slonomics for its industrial clients. SlonoGene is a tailored service offering gene customization and optimization suited perfectly to the needs of its customers. | Corporate Officer/Principal | 20/10/2008 |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Sloning Bio Technology GmbH
Sloning Bio Technology GmbH Miscellaneous Commercial ServicesCommercial Services Sloning BioTechnology specializes in the production of highly genetically diverse and precise customized libraries. The company offers high quality, innovative, tailored protein engineering solutions to its industrial and biopharmaceutical customers worldwide. As a business specializing in the development and production of genetically diverse libraries, Sloning BioTechnology GmbH offers high quality, innovative, tailored protein engineering solutions to its industrial and biopharmaceutical customers worldwide. The firm's Slonomics core technology is a unique DNA engineering platform that uses defined sets of double stranded DNA triplets to precisely introduce the required mutations into any DNA sequence. This multiply validated technology takes a novel approach to enable the realization of highly complex design concepts while at the same time ensuring that libraries generated by Sloning have the very highest standards of reliability. It harnesses the capabilities of Slonomics to synthesize SlonoMax and SlonoMax libraries are customized mutant libraries that significantly improve the efficiency of screening for new and improved proteins for therapeutic, enzymatic or technical applications. In addition, it offers a premium gene synthesis service using Slonomics for its industrial clients. SlonoGene is a tailored service offering gene customization and optimization suited perfectly to the needs of its customers. | Commercial Services |
